116
Participants
Start Date
February 28, 2010
Primary Completion Date
January 31, 2011
Study Completion Date
February 28, 2011
rebamipide 2% ophthalmic suspension
Instill one drop in each eye four times daily for 12 weeks.
placebo eye drops
Instill one drop in each eye four times daily for 12 weeks.
New York Ophthalmology, PC, Manhasset
Mundorf Eye Center, Charlotte
Med Eye Associates, Miami
Florida Eye Microsurgical Institute, Inc., Boynton Beach
Cohen Laser and Vision Center, Boca Raton
George R. John, MD, Louisville
Black Hills Regional Eye Institute, Rapid City
Ophthalmology Associates, St Louis
The Cataract & Glaucoma Center, El Paso
Corneal Consultants of Colorado, Littleton
Specialty Eye Care, Parker
Arizona Center for Clinical Trials, LLC, Phoenix
Cornea Consultants of Arizona, Phoenix
East Valley Ophthalmology, Mesa
Nevada Eye Care Professionals, Las Vegas
Avista Eye Center, Las Vegas
Macy Eye Center, Los Angeles
Central Maine Eye Care, Lewiston
Ora, Inc., Andover
Lead Sponsor
Collaborators (1)
Otsuka Pharmaceutical Co., Ltd.
INDUSTRY
Kubota Vision Inc.
INDUSTRY